BATS:ARKG ARK Genomic Revolution ETF (ARKG) Price, Holdings, & News → This consistently signaled gains of 453%... 610%... and even 1036%... (From Insiders Exposed) (Ad) Free ARKG Stock Alerts $28.55 +0.65 (+2.33%) (As of 03/27/2024 ET) Add Compare Share Share Today's Range$27.81▼$28.5750-Day Range$27.93▼$32.9752-Week Range N/AVolume1.21 million shsAverage VolumeN/AMarket Capitalization$1.86 billionAssets Under Management$1.59 billionDividend YieldN/ANet Expense Ratio0.75% Stock AnalysisStock AnalysisChartHeadlinesHoldingsOwnershipRatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatings Get ARK Genomic Revolution ETF alerts: Email Address About ARK Genomic Revolution ETF (BATS:ARKG)The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.Read More ARKG Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ARKG ETF News HeadlinesMarch 26, 2024 | markets.businessinsider.comCathie Wood's Ark Takes Profits In Rallying Crypto Stocks, Trims Nvidia And This COVID-19 Play FurtherMarch 25, 2024 | fool.comCathie Wood Is Selling This High-Yield Dividend Stock. Should You?March 28, 2024 | Crypto 101 Media (Ad)SHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. March 19, 2024 | investorplace.com3 Biotech ETFs Overdue for a BounceFebruary 23, 2024 | markets.businessinsider.comHere's How Much Cathie Wood, Ark Invest Flagship Fund Missed By Selling Nvidia EarlyFebruary 23, 2024 | wsj.comARK Genomic Revolution ETFFebruary 7, 2024 | markets.businessinsider.comCathie Wood's Ark Invest Sheds $2.8M Worth Of Nvidia Shares Amid AI Hype, Picks Up Robinhood Stock Worth $1.3MFebruary 1, 2024 | msn.comAI Revolution Ignited? Ark Invest Predicts 75% Annual Drop In Training Costs By 2030March 28, 2024 | Huge Alerts (Ad)Trending Stocks Sent To You In Real Time Sign up today and get instant access to our next stock alert! You do not want to miss out on this next pick! Our stock picks have been known to soar! January 16, 2024 | markets.businessinsider.comCathie Wood's Ark Invest Liquidates $15.8M Worth Of ProShares Bitcoin Strategy ETF UnitsSee More Headlines Receive ARKG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ARK Genomic Revolution ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerARK Fund NameARK Genomic Revolution ETF Tax ClassificationRegulated Investment Company Stock ExchangeBATSCurrent SymbolBATS:ARKG Inception Date10/31/2014 Fund ManagerCatherine Wood WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkN/A CategoryStrategy FocusTheme Development LevelBlended Development RegionGlobal Number of Holdings43 Fund Statistics Assets Under Management$1.57 billion Average Daily Volume$2.05 million Discount/Premium-0.04% Administrator, Advisor and Custodian AdministratorThe Bank of NewYork Mellon Corporation AdvisorARK Investment Management LLC CustodianThe Bank of NewYork Mellon Corporation DistributorForeside Fund Services, LLC Transfer AgentThe Bank of NewYork Mellon Corporation TrusteeN/A Lead Market MakerJane Street Options OptionableOptionable Options Volume2,629 Put Options652 Call Options1,977 Miscellaneous Outstanding Shares65,100,000Beta1.50 Creation Unit50,000 Creation Fee$500.00 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Ad DTIWarning: this could blow your mindBuckle up… ‘Cause this might shatter everything you’ve heard about “income trading”. In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it: The Perfect Income Trade You see, most of the income techniques out there target a couple of percent. Maybe 5 - 10 percent if you’re lucky. But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return. And here’s the best news of all: This trade can target an opportunity like that every week. Every single week. Meaning an investor has the chance to “stack up” these more aggressive income trades over and over. If that sounds interesting…Watch the presentation here ARK Genomic Revolution ETF ExpensesTypeARKGTheme ETFsEquity ETFsBATS ETFsAll ETFsManagement Fee0.75%0.57%0.54%0.56%0.51%Other Expenses0.00%0.71%0.54%0.52%0.58%Total Expense0.75%0.72%0.70%0.69%0.70%Fee Waiver0.00%-0.76%-0.54%-0.34%-0.56%Net Expense0.75%0.59%0.60%0.63%0.58% ARK Genomic Revolution ETF (ARKG) Holdings & ExposureTop 10 ARKG HoldingsExact Sciences(NASDAQ:EXAS)Holding Weight: 9.79%Schrödinger(NASDAQ:SDGR)Holding Weight: 7.61%Pacific Biosciences of California(NASDAQ:PACB)Holding Weight: 6.11%Teladoc Health(NYSE:TDOC)Holding Weight: 4.60%Ginkgo Bioworks(NYSE:DNA)Holding Weight: 4.47%Ionis Pharmaceuticals(NASDAQ:IONS)Holding Weight: 4.37%Adaptive Biotechnologies(NASDAQ:ADPT)Holding Weight: 3.80%Accolade(NASDAQ:ACCD)Holding Weight: 3.71%CRISPR Therapeutics(NASDAQ:CRSP)Holding Weight: 3.53%CareDx(NASDAQ:CDNA)Holding Weight: 3.36%ARKG Sector ExposureARKG Industry ExposureFull Holdings Details Similar ETFsGlobal X Future Analytics Tech ETFNASDAQ:AIQSPDR S&P Fossil Fuel Reserves Free ETFNYSEARCA:SPYXARK Next Generation Internation ETFNYSEARCA:ARKWiShares Paris-Aligned Climate MSCI USA ETFNASDAQ:PABUAmplify Cybersecurity ETFNYSEARCA:HACKInstitutional OwnershipICA Group Wealth Management LLCBought 2,023 shares on 3/8/2024Ownership: 0.003%Goldman Sachs Group Inc.Bought 469,740 shares on 3/1/2024Ownership: 0.987%Scarborough Advisors LLCBought 5,705 shares on 2/22/2024Ownership: 0.009%Prospect Financial Services LLCBought 13,123 shares on 2/20/2024Ownership: 0.020%Clarity Capital Partners LLCBought 8,926 shares on 2/20/2024Ownership: 0.014%View All Institutional Transactions ARKG ETF - Frequently Asked Questions How have ARKG shares performed in 2024? ARK Genomic Revolution ETF's stock was trading at $32.81 at the beginning of the year. Since then, ARKG stock has decreased by 13.0% and is now trading at $28.56. View the best growth stocks for 2024 here. What does ARKG invest in? ARK Genomic Revolution ETF is a equity fund issued by ARK. ARKG focuses on theme investments. The fund's investments total to approximately $1.57 billion assets under management. What stocks does ARK Genomic Revolution ETF hold? ARKG invests in 43 holdings. Some of the stocks in their portfolio include Exact Sciences (EXAS), Schrödinger (SDGR), Pacific Biosciences of California (PACB), Teladoc Health (TDOC), Ginkgo Bioworks (DNA), Ionis Pharmaceuticals (IONS), Adaptive Biotechnologies (ADPT), Accolade (ACCD), CRISPR Therapeutics (CRSP) and CareDx (CDNA). What is the management fee for ARK Genomic Revolution ETF? ARK Genomic Revolution ETF's management fee is 0.75% and has no other recorded expenses or fee waivers. The net expense ratio for ARKG is 0.75%. Who are ARK Genomic Revolution ETF's major shareholders? ARK Genomic Revolution ETF's stock is owned by many different institutional and retail investors. Top institutional investors include IMC Chicago LLC (0.00%), BNP Paribas Financial Markets (1.78%), Wells Fargo & Company MN (1.19%), Main Management LLC (1.05%), Goldman Sachs Group Inc. (0.99%) and Goldman Sachs Group Inc. (0.99%). How do I buy shares of ARK Genomic Revolution ETF? Shares of ARKG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (BATS:ARKG) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThe 3rd Revolution in WarfareWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ARK Genomic Revolution ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.